EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Efficacy and safety of durvalumab + chemotherapy vs. atezolizumab + chemotherapy in the treatment of small-cell lung cancer: a retrospective comparative cohort study

Yuxia Zou, Xueru Ren, Huanhuan Zhang, Yuenan Wang, Hanqi Wang, Rubing Bai, Zhihong Zhang, Gengyun Sun, Ling Xu

Journal of Thoracic Disease · 2023-06 · 15 (6) · 3339-3349

DOI: 10.21037/jtd-23-588 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Thoracic Disease, 2023-06. Verfasst von Yuxia Zou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Oncology, The Anhui Provincial Cancer Hospital/The First Affiliated Hospital of University of Science and Technology of Chi…. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Atezolizumabdurvalumabimmune-related adverse eventsoverall survivalprogression-free survival

Autor:innen und Institutionen

  • Department of Respiratory Oncology, The Anhui Provincial Cancer Hospital/The First Affiliated Hospital of University of Science and Technology of China (USTC) West District, Hefei, China.
  • Department of Respiratory Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Interventional Pulmonary Diseases, The Anhui Chest Hospital, Hefei, China.

Zitieren

APA

Zou, Y., Ren, X., Zhang, H., Wang, Y., Wang, H., Bai, R., Zhang, Z., Sun, G., & Xu, L. (2023). Efficacy and safety of durvalumab + chemotherapy vs. atezolizumab + chemotherapy in the treatment of small-cell lung cancer: a retrospective comparative cohort study. Journal of Thoracic Disease, 15(6), 3339-3349. https://doi.org/10.21037/jtd-23-588

Vancouver

Zou Y, Ren X, Zhang H, Wang Y, Wang H, Bai R, et al. Efficacy and safety of durvalumab + chemotherapy vs. atezolizumab + chemotherapy in the treatment of small-cell lung cancer: a retrospective comparative cohort study. Journal of Thoracic Disease. 2023;15(6):3339-3349. doi:10.21037/jtd-23-588

BibTeX
@article{Zou2023,
  author = {Zou, Yuxia and Ren, Xueru and Zhang, Huanhuan and Wang, Yuenan and Wang, Hanqi and Bai, Rubing and Zhang, Zhihong and Sun, Gengyun and Xu, Ling},
  title = {Efficacy and safety of durvalumab + chemotherapy vs. atezolizumab + chemotherapy in the treatment of small-cell lung cancer: a retrospective comparative cohort study},
  journal = {Journal of Thoracic Disease},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {3339--3349},
  doi = {10.21037/jtd-23-588}
}
Kostenlos starten →